Bartlett MG
ORCID: 0000-0003-0626-3234
· 1 paper in corpus
BackgroundAlthough the incidence of melanoma in the U.S. is rising faster than any other cancer, the FDA-approved chemotherapies lack efficacy for advanced disease, which results in poor overall survival. Lysophosphatidic acid (LPA), autota…